KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”), today announced that it will present at the 18th Annual BIO CEO & Investor Conference.
The Company’s presentation is currently scheduled for 3:00 pm Eastern Standard Time on Monday, February 8, 2016. The presentation is scheduled to take place in the Duke of Windsor room at the Waldorf Astoria Hotel in New York, New York.
